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Abstract Neutrophils are important innate immune cells that tackle invading pathogens with
different effector mechanisms. They acquire this antimicrobial potential during their maturation in
the bone marrow, where they differentiate from hematopoietic stem cells in a process called
granulopoiesis. Mature neutrophils are terminally differentiated and short-lived with a high turnover
rate. Here, we show a critical role for linker histone H1 on the differentiation and function of
neutrophils using a genome-wide CRISPR/Cas9 screen in the human cell line PLB-985. We
systematically disrupted expression of somatic H1 subtypes to show that individual H1 subtypes
affect PLB-985 maturation in opposite ways. Loss of H1.2 and H1.4 induced an eosinophil-like
transcriptional program, thereby negatively regulating the differentiation into the neutrophil
lineage. Importantly, H1 subtypes also affect neutrophil differentiation and the eosinophil-directed
bias of murine bone marrow stem cells, demonstrating an unexpected subtype-specific role for H1
in granulopoiesis.
Introduction
Because multicellular organisms often face disturbances in their homeostasis, they evolved complex
immune responses to deal with sterile and infectious insults. Like elsewhere in the human body,
immune cells differentiate from multipotent precursors. In the immune context, precursors are pri-
marily hematopoietic stem cells in the bone marrow. One of these differentiation programs, called
granulopoiesis, leads to the development of granulocytes - basophils, eosinophils and neutrophils.
Neutrophils are the most abundant leukocytes in humans. In homeostatic conditions, up to 2  1011
neutrophils enter the blood stream per day and patrol the host’s body until they sense signs of infec-
tion, which triggers them to leave the blood stream and migrate to the inflammatory site where they
ensure pathogen removal. An efficient neutrophil response is crucial for human antimicrobial defense
and, correspondingly, neutropenia is associated with severe infections (Klein, 2011).
The three best described defense mechanisms of neutrophils are phagocytosis (engulfment of
pathogenic microorganisms and subsequent destruction in phagosomes), degranulation (the release
of antimicrobial proteins from granules to the extracellular space) and the formation of neutrophil
extracellular traps (NETs). NETs are chromatin structures studded with antimicrobial proteins derived
mostly from neutrophil granules, which can trap pathogens (Papayannopoulos, 2018). Neutrophils
release NETs via various mechanisms, which in most cases lead to neutrophil death (Kenny et al.,
2017); thus, NETs are an extreme form of antimicrobial defense, as their release also eliminates the
cell casting the NET. Under homeostatic conditions, NET formation occurs in mature, circulating neu-
trophils and therefore we propose that specific cues during neutrophil differentiation shape their
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ability to form NETs. It is noteworthy that during systemic inflammation, some neutrophils, called
low density granulocytes, display signs of immaturity, but enhanced formation of NETs
(Denny et al., 2010; Villanueva et al., 2011). In inflammatory settings the requirement for full differ-
entiation might therefore be less stringent.
Neutrophils differentiate from granulocyte-macrophage precursors. The first progenitor with a
clear neutrophil lineage preference during granulopoiesis is the promyelocyte (Yvan-Charvet and
Ng, 2019). During maturation, neutrophils acquire a lobulated nuclear shape and produce many of
their antimicrobial effector proteins, stored in granules (Borregaard, 2010). Granulopoiesis requires
balanced activity of various transcription factors (Yvan-Charvet and Ng, 2019). The C/EBP family,
especially C/EBP-a and –e, are key regulators of neutrophil differentiation (Zhang et al., 1997;
Yamanaka et al., 1997). Other transcription factors can antagonize C/EBP-dependent neutrophil
development. For example, expression of GATA-1 (Yu et al., 2002) and GATA-2 (Hirasawa et al.,
2002) induce eosinophil, basophil or mast cell differentiation (Fiedler and Brunner, 2012).
Differentiation programs rely both on transcription factor activation and on epigenetic chromatin
alterations. DNA wraps around an octamer of core histones forming a nucleosome. The linker his-
tone H1 binds to nucleosomes and further compacts chromatin (Bednar et al., 2017). There are 11
different H1 subtypes in mice and humans. Five of them (H1.1 – H1.5) are somatic replication-depen-
dent subtypes, two (H1.0 and H1X) are somatic and replication-independent and four (H1oo, H1t,
H1T2 and HILS1) are germline-specific (Hergeth and Schneider, 2015). All H1 subtypes consist of a
highly conserved globular domain and two more variable regions: the N- and the C-terminal tails.
Individual H1 subtypes are more conserved between species than H1 subtypes are within one spe-
cies, suggesting that the conservation of different subtypes has functional relevance (Hergeth and
Schneider, 2015). Still, some functions of H1, such as global shaping of chromatin structure, are
redundant between subtypes. This is reflected by the fact that mice deficient for one or even two H1
subtypes are viable and fertile without striking morphological abnormalities (Fan et al., 2003). How-
ever, mice lacking three H1 subtypes die in utero, with total H1 levels reduced to about 50%
(Fan et al., 2003). Appropriate H1 expression is therefore essential for development. Despite some
redundancy, H1 subtypes have specific functions. H1 subtypes bind to chromatin with different affini-
ties and knock down of specific H1 subtypes affects gene transcription in distinct ways
(Hendzel et al., 2004; Th’ng et al., 2005; Sancho et al., 2008).
The role of H1 and H1 subtypes in immunity is poorly understood. H1 contributes to the silencing
of pro-inflammatory cytokines after endotoxin challenge (El Gazzar et al., 2009), as well as to the
silencing of interferon-stimulated genes (Kadota and Nagata, 2014). Interestingly, mice deficient in
H1.0 have fewer dendritic cells, but normal numbers of granulocytes, macrophages and lympho-
cytes, showing a subtype-specific role for H1 in dendritic cell differentiation (Gabrilovich et al.,
2002). However, to date, no studies have systematically addressed H1 subtype involvement in the
maturation and function of human immune cells.
Here we used the human neutrophil-like cell line, PLB-985, to study neutrophil maturation and
function. We performed a genome-wide CRISPR/Cas9 screen using survival to a NET-inducing stimu-
lus, phorbol 12-myristate 13-acetate (PMA), as a readout. Surprisingly, we found that depletion of
either H1.2 or H1.4 strongly reduced the differentiation of PLB-985 and thereby their ability to form
NETs. Notably, deficiency of the other somatic H1 subtypes, H1.1, H1.3 and H1.5, accelerated PLB-
985 maturation. RNA-seq analysis showed that H1.2 and H1.4 deficiency leads to an upregulation of
eosinophil genes in PLB-985. Mirroring these results, murine bone marrow stem cells from H1.2/
H1.4 double deficient mice shifted their differentiation profile from neutrophil towards eosinophil
cell fate, whereas neutrophils in vivo displayed disturbances in ageing markers. We further demon-
strate that the subtype-specific function of H1 in neutrophil and eosinophil differentiation depends –
at least in part – on the transcription factor GATA-2. We uncovered that, unexpectedly, H1 subtypes
affect lineage specification during granulopoiesis.
Results
PLB-985: a model for neutrophil maturation and function
We used the human promyelocytic cell line PLB-985 (Tucker et al., 1987). PLB-985 differentiate into
neutrophil-like cells that resemble primary human neutrophils in various ways (Zhen et al., 1993;
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Pedruzzi et al., 2002; Pivot-Pajot et al., 2010; Marin-Esteban et al., 2012). PLB-985 changed their
nuclear morphology and developed granules, though fewer than primary neutrophils, throughout
the 7 days of differentiation (referred as d0 to d7 in this report) (Figure 1a). Once differentiated,
PLB-985 also produced ROS in response to the agonist phorbol 12-myristate 13-acetate (PMA)
(Figure 1b, Figure 1—figure supplement 1a) and upregulated the surface marker CD11b
(Figure 1c). Furthermore, differentiated PLB-985 phagocytosed Escherichia coli, a process that could
be blocked by the phagocytosis inhibitor cytochalasin B (Figure 1—figure supplement 1b). Impor-
tantly, PMA potently induced cell death in fully differentiated PLB-985, but not in d0 or d3 cells
(Figure 1d). PMA-induced cell death was morphologically similar to NETosis; dying PLB-985
expanded their nuclei and a significant fraction released DNA as shown by SYTOX Green staining
(Figure 1e, Figure 1—figure supplement 1c). Of note, the calcium ionophore A23187, another
stimulant of NET formation, also induced cell death in PLB-985, both at d3 and d7 of differentiation
(Figure 1—figure supplement 1d). Taken together, these experiments show that PLB-985 cells dif-
ferentiate into neutrophil-like phagocytes that produce ROS and NETs.
To show that PLB-985 can be genetically modified by CRISPR/Cas9, we disrupted expression of
NOX2 (CYBB), a component of the NADPH oxidase complex, which is required for PMA-induced
NETosis (Fuchs et al., 2007). We also transduced PLB-985 with a non-target scrambled single-guide
RNA (sgRNA) as a control (subsequently called scr.). Differentiated PLB-985 cells lacking NOX2
failed to produce an oxidative burst and did not undergo cell death in response to PMA (Figure 1—
figure supplement 1e,f). To inactivate NADPH oxidase independently of NOX2, we also disrupted
expression of its NCF2 subunit, and showed again that these cells did not die upon PMA stimulation
(Figure 1—figure supplement 1g). These results demonstrate that PLB-985, which can be geneti-
cally modified, are a suitable model to mimic human neutrophils.
A genome-wide screen to identify regulators of neutrophil maturation
and function
We found that PMA-induced NET formation required full differentiation of PLB-985. Therefore, we
used this readout to perform a genome-wide CRISPR/Cas9 screen to identify genes required for
neutrophil maturation and function (Figure 1f). We reasoned that, besides NET-defective cells, we
could also identify differentiation-defective cells by sorting cells that survived PMA treatment. We
transduced PLB-985 with a library targeting all human genes with 5–6 sgRNAs per gene
(Shalem et al., 2014). As expected, PMA stimulation reduced the fraction of identified guides in the
survivor population (Figure 1—figure supplement 1h), indicating selection of specific clones.
We defined ‘hits’ as genes for which at least 50% of the identified sgRNAs were overrepresented
(more than two-fold) in our survivor population. Underlining the validity of the screening approach,
we identified CYBB, NCF1 and MPO as hits; all three are known to be required for PMA-induced
NET formation (Fuchs et al., 2007; Metzler et al., 2011; Figure 1g, Figure 1—source data 1). We
also found CEBPD, a member of the C/EBP family of transcription factors that are crucial for granulo-
poiesis (Wang and Friedman, 2002; Figure 1g). Unexpectedly, we identified two members of the
linker histone H1 family among the 20 highest ranked genes. HIST1H1E (H1.4) was overrepresented
with 100% of sgRNAs and showed the highest median enrichment (Figure 1g, Figure 1—source
data 1). Notably, there are no studies showing a functional role of H1 in neutrophil differentiation or
NET formation.
H1.4 and H1.2 affect neutrophil function through differentiation
There are five somatic replication-dependent (H1.1 – H1.5) and two replication-independent H1 sub-
types (H1.0 and H1X). PLB-985 expressed mRNA encoding H1.2 and H1.4 more abundantly than the
other subtypes (Figure 2a). The expression of replication-dependent H1 subtypes occurs mainly in
the S phase of proliferating cells and, accordingly, H1 mRNA levels decreased during PLB-985 differ-
entiation (Figure 2—figure supplement 1a, same experiments as in Figure 2a, but plotted as rela-
tive to d0). As expected, this reduction was more evident for subtypes with a higher baseline
expression (Figure 2a, Figure 2—figure supplement 1a). When we looked at H1.2 and H1.4 protein
expression of PLB-985 during differentiation, we found that protein levels also decreased as the cells
matured (Figure 2—figure supplement 1b).
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Figure 1. A genome-wide screen to identify genes required for PLB-985 cells differentiation and function. (a–d) Characterization of PLB-985
differentiation and function at d0, d3 and 7 of differentiation. (a) Electron microscopy images of PLB-985 showing acquisition of granules (green arrows,
the black arrow at d0 indicates mitochondria) and changes in nuclear morphology. Scale bars correspond to 5 mm. (b) ROS production of PLB-985 in
response to 100 nM PMA, showing that only fully differentiated PLB-985 produced an oxidative burst. (c) Surface expression of CD11b, depicted is the
Figure 1 continued on next page
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We also analyzed two datasets comparing mRNA and protein expression of human primary bone
marrow cells undergoing differentiation into neutrophils at various stages of maturation, namely
myelocytes, metamyelocytes, band form neutrophils and segmented neutrophils (Adams et al.,
2012; Hoogendijk et al., 2019) (see Materials and methods section for RNA-seq). Consistent with
our PLB-985 data, we found a similar reduction of H1 mRNA as maturation progressed (Figure 2—
figure supplement 1c). The protein levels of H1 subtypes in these datasets remained relatively sta-
ble during differentiation, despite a reduction in mRNA (Figure 2—figure supplement 1c,d). Hence,
all H1 subtypes are expressed in differentiating primary neutrophils and although the mRNA levels
decrease over time of differentiation, the protein levels seem to be relatively stable.
mRNA levels of each H1 subtypes were still detectable in differentiated PLB-985 and primary
cells. Accordingly, human primary neutrophils isolated from blood of healthy donors expressed
detectable amounts of the H1 genes. H1.2 and H1.4, the two hits in our genome wide screen, were
the most abundantly expressed subtypes (Figure 2b). Interestingly, peripheral blood mononuclear
cells (PBMCs) and monocytes showed a slightly different expression pattern of this gene family than
neutrophils (Figure 2—figure supplement 1e,f).
To verify the results from our screen, we disrupted expression of H1.2 and H1.4 in PLB-985 by tar-
geting these genes with CRISPR/Cas9. We used two clones deficient for H1.2 (from two sgRNAs)
and two clones deficient for H1.4 (from one sgRNA) in our analysis. Cell death was reduced in both
H1.2 and H1.4-deficient clones, confirming the results of the screen (Figure 2c). H1.2 and H1.4-defi-
cient clones produced ROS less efficiently than wild type cells upon PMA stimulation (Figure 2d).
Furthermore, cells deficient for either of the two H1 subtypes expressed less MPO (Figure 2e). Cells
deficient for H1.2 or H1.4 could still phagocytose, demonstrating that not all effector functions were
equally affected by the loss of H1 subtypes (Figure 2—figure supplement 1g,h). These findings sug-
gest that H1.2 and H1.4 are required for PLB-985 to differentiate into mature, neutrophil-like cells.
Opposing effects of H1 subtypes on neutrophil differentiation
To confirm that deficiency of H1.2 and H1.4 affected PLB-985 maturation, we showed that surface
expression of the differentiation marker CD11b is decreased on both d3 and d7 of differentiation
(Figure 3a,b, Figure 3—figure supplement 1a,b) in cells where these genes were deleted. We also
disrupted expression of the other three somatic H1 subtypes. Surprisingly, loss of these subtypes
resulted in the opposite phenotype. We observed markedly enhanced expression of CD11b already
at d3, especially in clones deficient in H1.1 and H1.5 (Figure 3a,b, Figure 3—figure supplement 1a,
b). To test whether these effects were specific to neutrophilic cells, we also disrupted expression of
H1 subtypes in the monocytic cell line THP-1 and analyzed their ability to release IL-1b via the
NLRP3 inflammasome. Batch populations of H1-deficient cells released similar amounts of IL-1b than
control cells when activated with silica crystals (Figure 3—figure supplement 1c). We therefore con-
clude that loss of H1 subtypes does not generally impact myelopoiesis or innate immune functions.
Differentiation of neutrophils and PLB-985 is terminal - if not activated, these cells die by apopto-
sis. The number of wild type and control (scr.) PLB-985 cells increased more from d0 to d3 than from
d3 to d7. This suggests that cells withdrew from proliferation (Figure 3c). Interestingly, H1.2 and
H1.4-deficient clones grew unrestrictedly until d7, whereas cells deficient in H1.1, H1.3 and H1.5
decreased in comparison to controls (Figure 3c,d). Furthermore, control cells successively lost viabil-
ity from d8 to d12 (Figure 3e,f). In line with their enhanced growth, H1.2 and H1.4-deficient cells
Figure 1 continued
percentage of CD11b positive cells out of all viable singlets. (d) PMA-induced cell death was measured over time after addition of the cell-impermeable
DNA dye SYTOX Green and analysis of fluorescence indicating cell death. ‘d7 naı̈ve’ indicates differentiated cells, which were not treated with PMA. (e)
Representative images of differentiated PLB-985 (d7) after addition of SYTOX Green and treatment with or without PMA. Scale bars are 20 mm. (f)
Outline of the CRISPR/Cas9 screen. Cells were transduced with a genome-wide CRISPR/Cas9 library (lentiviral particles, small circles), differentiated for
7 days, treated with PMA for 16 hr and survivors were sorted and sequenced to identify sgRNAs. (g) Top 10 of the screen, H1.2 (HIST1H1C) and
indicated genes with known neutrophil functions, ranked first by % of overrepresented guides and then by median overrepresentation and mapped to
a proteome list of human primary neutrophils. (b–d) Depicted are mean -/+ SEM of 3 independent experiments.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. List of genes identified as hits in the CRISPR/Cas9 screen.
Figure supplement 1. Characterization of PLB-985 function and morphology.
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Figure 2. H1.2 and H1.4 are required for PLB-985 differentiation. (a) mRNA expression levels of indicated H1 subtypes (nomenclature refers to protein
names) in PLB-985 cells at d0, d3 and d7 of differentiation, relative to the housekeeping gene b-microglobulin, depicted is the mean -/+ SEM of 3
independent experiments. (b) mRNA expression levels of indicated H1 subtypes in human primary neutrophils, relative to b-microglobulin. Data points
are from four different donors, error bars are mean -/+ SEM. (c) PMA-induced cell death of wild type (wt) scrambled sgRNA (non-target, scr.) and two
Figure 2 continued on next page
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were more viable than controls, whereas H1.1, H1.3 and H1.5-deficient cells showed less viability
than controls (Figure 3e,f). Of note, cells deficient in H1.1 had a stronger oxidative burst in response
to PMA than control cells, consistent with enhanced maturation (Figure 3—figure supplement 1d).
Clones deficient in H1.3 and H1.5, on the other hand, produced less ROS than control cells (Fig-
ure 3—figure supplement 1e,f). This could be a specific effect of H1.3 and H1.5, but it could also
reflect reduced viability at the onset of the experiment. In summary, these experiments show an
unexpected and opposing effect of H1 subtypes on PLB-985 cell differentiation and function.
The impact of H1 deficiency manifests before onset of differentiation
To understand the extent of H1 subtype-specific effects on neutrophil differentiation we performed
RNA-sequencing of the knockout lines. We sampled wild type cells, scr. cells and two clones per H1
subtype at d0, d3 and d7 of differentiation in four independent experiments (Figure 4—source data
1). To validate the applicability of our experiment, we compared the transcriptome of control PLB-
985 cells (the combination of wild type and scr. samples) to human primary cells at various differenti-
ation stages towards neutrophils (Adams et al., 2012) (also see Materials and methods section).
Gene set enrichment analysis demonstrated that PLB-985 and primary cells concordantly regulate
processes during differentiation (Figure 4a, Figure 4—figure supplement 1a,b. Figure 4—figure
supplement 1a depicts the same analysis as Figure 4a with the gene set labels). Using principal
component analysis (PCA), we saw that these cells follow a similar differentiation trajectory (Fig-
ure 4—figure supplement 1c). As expected, among the most robustly upregulated genes during
differentiation of control cells we found several with known functions in neutrophils (Figure 4b).
We analyzed the H1-deficient clones by PCA and found that H1.2 and H1.4-deficient clones at d7
clustered more closely with control cells at d3, indicating delayed differentiation (Figure 4c). H1.1,
H1.3 and H1.5-deficient cells at d3 clustered with control cells at d7, suggesting accelerated differ-
entiation (Figure 4c).
Analysis of the enrichment of gene modules confirmed that, during differentiation, control cells
upregulated genes related to the innate immune response and downregulated genes corresponding
to cell cycle and division, in line with the context of terminal differentiation (Figure 4—figure sup-
plement 1d). Interestingly, in H1.2 and H1.4-deficient cells, the modules were less regulated, again
demonstrating prolonged proliferation and obstruction of differentiation (Figure 4—figure supple-
ment 1d). We performed the same analysis for clones deficient in H1.1, H1.3 and H1.5 and con-
firmed accelerated differentiation (Figure 4—figure supplement 1d). We subsequently asked
whether absence of H1 subtypes also affected the determination and lineage choice of PLB-985
before differentiation. To address this question, we compared differentially expressed genes of H1.2
and H1.4-deficient cells and control cells at d0. We found that both H1.2 and H1.4-deficient cells
downregulated neutrophil genes, such as MPO and neutrophil proteases among others (Figure 4d),
indicating that lineage fate was affected in undifferentiated cells.
Surprisingly, among the upregulated genes we found a significant number of genes associated
with eosinophils and a GATA-1 signature (Figure 4d,e, see Materials and methods section for the
source of datasets). We found this upregulation specifically in clones deficient in H1.2 and H1.4 in
comparison to all other genotypes (Figure 4e). This suggests that loss of H1.2 and H1.4 affects line-
age determination of PLB-985 cells even before the onset of differentiation by driving them towards
a more eosinophil-like fate. Notably, we also saw dysregulation of C/EBP family transcription factors
in cells deficient for different H1 subtypes (Figure 4—figure supplement 2). We found downregula-
tion of CEBPA in cells deficient for H1.2 and H1.4 at d0, but upregulation of the same transcription
Figure 2 continued
clones of either H1.2 or H1.4 over time, measured by SYTOX Green fluorescence. Depicted are mean -/+ SEM of 5 independent experiments of cells at
d7 of differentiation. (d) Measurement of PMA-induced ROS production from wt, scr. and H1.2 or H1.4 deficient PLB-985, depicted are mean -/+ SEM
of 5 independent experiments at d7 of differentiation. (c, d) wt and scr. values are the same in the left and right panels, respectively. (e) Western blot of
lysates of PLB-985 at d3 of differentiation, showing efficient disruption of H1.2 and H1.4 (both antibodies recognize the other subtype, which is marked
by a red asterisk for H1.2 and a blue asterisk for H1.4) as well as reduced MPO expression, the core histone H3 served as loading control.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. H1 expression levels in human PBMCs, monocytes and PLB-985.
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Figure 3. H1 effects on PLB-985 differentiation are subtype-specific. (a, b) Expression of the surface marker CD11b
at d3 (a) or d7 (b) of differentiation. Depicted is the percentage of CD11b-positive cells out of all living singlets for
wt, scrambled (scr.) and two knockout clones per H1 subtype. (c, d) Growth curves of PLB-985 during
differentiation (c) and cell counts at d7 of differentiation (d) show restricted growth of H1.1, H1.3 and H1.5-
Figure 3 continued on next page
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factors in cells deficient for H1.1, H1.3 and H1.5 (Figure 4—figure supplement 2). This is in line with
decreased and enhanced maturation, respectively. Other C/EBP family members also showed dysre-
gulated expression patterns in H1-deficient clones (Figure 4—figure supplement 2). Our data indi-
cate that H1 subtype depletion affects both cell fate determination and differentiation per se.
Enhanced eosinophil differentiation of H1.2/H1.4-deficient
hematopoietic stem cells
Loss of H1.2 and H1.4 appears to bias the lineage commitment of PLB-985 away from neutrophils
via regulation of an eosinophil-like transcriptional program. We therefore analyzed the morphology
of these cells by transmission electron microscopy. There was no obvious morphological difference
between genotypes (Figure 4—figure supplement 3a). However, loss of H1.2 and H1.4 led to
enhanced expression of the eosinophil marker Siglec-8 on the surface of a subset of PLB-985 (Fig-
ure 4—figure supplement 3b). H1.2- and H1.4-deficient PLB-985 also expressed higher levels of the
eosinophil protein galectin-10/CLC, in line of what we had seen by RNA-seq (Figure 4—figure sup-
plement 3c,d). We therefore conclude that even though PLB-985 do not become fully functional
eosinophils in our differentiation system, H1.2 and H1.4 deficiency leads to enhanced expression of
some eosinophil proteins. We also looked at H1 mRNA expression levels in human primary eosino-
phils and found that these cells expressed very high levels of H1.2 and H1.4 (Figure 4—figure sup-
plement 3e). A proteomics dataset of cells in circulation confirmed high expression levels of H1
subtypes in eosinophils (Figure 4—figure supplement 3f; Rieckmann et al., 2017), suggesting that
eosinophil maturation relies on an appropriate amount of H1 subtype expression during
differentiation.
To test whether this eosinophil bias also exists in primary cells, we analyzed cells isolated from
H1.2/H1.4 double-deficient mice (Fan et al., 2003). The profile of circulating lymphocytes and
monocytes in the blood or bone marrow of adult animals was indistinguishable from wild type ani-
mals (Figure 5—figure supplements 1 and 2). Furthermore, wild type and H1.2/H1.4-deficient ani-
mals had the same proportion of neutrophils in circulation and in bone marrow (Figure 5a,b,
Figure 5—figure supplements 1 and 2). We also induced a sterile peritonitis in these animals by
injection of casein into the peritoneal cavity (Zhang et al., 1997). 24 hr upon injection the numbers
of circulating leukocytes and bone marrow leukocytes were similar between genotypes (Figure 5—
figure supplement 3).
Importantly, although the number of eosinophils in the bone marrow were similar between geno-
types (Figure 5—figure supplement 4a), H1.2/H1.4-deficient animals had enhanced amounts of cir-
culating eosinophils during homeostasis, suggesting that, in vivo, there is also bias towards
eosinophils (Figure 5c). The number of circulating neutrophils returned to the same level as in wild-
type animals upon casein injection (Figure 5—figure supplement 4b,c). In addition to a change in
eosinophil numbers in circulation, H1.2/H1.4-deficient mice showed disturbances in neutrophil age-
ing markers (Zhang et al., 2015; Adrover et al., 2019). We found similar expression of CD62L in
bone marrow neutrophils during homeostasis, but a slightly lower number of CD62L+ CXCR4-
‘young’ neutrophils (Zhang et al., 2015; Adrover et al., 2019) in H1.2/H1.4-deficient mice (Fig-
ure 5—figure supplement 5a–c,g). Upon casein injection, we found more CD62L+, but also more
CXCR4+ neutrophils in wildtype than in H1.2/H1.4-deficient animals (Figure 5—figure supplement
5d–f,h). These results suggest a slight disturbance of neutrophil ageing upon H1 deficiency. Interest-
ingly, we also found altered expression of cytokines and chemokines. H1.2/H1.4-deficient bone mar-
row cells expressed enhanced levels of the chemokine CXCL1, reduced amounts of IL6 mRNA, and
we also found enhanced levels of IL-17 upon casein injection (Figure 5—figure supplement 6a–d).
IL-17 affects granulopoiesis via G-CSF (Stark et al., 2005). Upon casein injection, the levels of
Figure 3 continued
deficient cells and enhanced growth of H1.2 and H1.4-deficient clones. (a–d) Depicted are five independent
experiments, error bars are SEM. (e, f) Viability, as determined by DAPI negative cells, at d8 (e) and d12 (f) of
differentiation of 3 independent experiments. Error bars are SEM.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Subtype-specific H1 impact on PLB-985 maturation and function.
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Figure 4. RNA-seq reveals H1 subtype-specific effects on differentiation and an eosinophilic signature of undifferentiated H1.2/H1.4 knockout lines. (a)
Concordantly and discordantly regulated genes when comparing PLB-985 differentiation (wt and scr., d0 to d7) and human neutrophil differentiation
(Blueprint, neutrophilic myelocyte to segmented neutrophil of bone marrow) using discordance scores and tmod. Most modules are concordantly
regulated. (b) Volcano plot of all differentially expressed genes of control cells (wt and scr.) between d7and d0, darker gray depicts p<0.05 and
logFC >2. A selection of strongly upregulated genes is labelled and neutrophil markers are highlighted in red. Expression of granule proteins, such as
MPO, neutrophil elastase (ELANE), proteinase 3 (PRTN3) and cathepsin G (CTSG) decreases during differentiation. (c) Principal component analysis
Figure 4 continued on next page
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G-CSF were similar between wild type and H1.2/H1.4-deficient animals (Figure 5—figure supple-
ment 6e). However, the response of bone marrow cells to G-CSF was altered upon loss of H1.2/
H1.4; these cells were more viable after overnight incubation in the presence of G-CSF than wild
type cells (Figure 5—figure supplement 7a). Furthermore, bone marrow cells of H1.2/H1.4-deficient
mice were more granular than wild type cells, which could reflect reduced spontaneous degranula-
tion or differentially aged cells (Adrover et al., 2020; Figure 5—figure supplement 7b). We also
looked at the granularity of neutrophils in circulation and in the bone marrow of animals during
homeostatic and inflammatory conditions. H1.2/H1.4-deficient neutrophils were more granular in the
bone marrow, both during homeostasis and upon casein injection, but not in circulation (Figure 5—
figure supplement 7c,d). Taken together, we concluded that the altered cytokine and chemokine
milieu in these mice might lead to compensatory effects on the maturation of neutrophils in vivo.
To analyze the intrinsic differentiation potential of H1.2/H1.4-deficient cells in the absence of con-
founding factors, we isolated lineage negative cells from murine bone marrow and differentiated
them into several lineages (Dahlin et al., 2018). Importantly, H1.2/H1.4-deficient cells expressed ele-
vated levels of surface markers for eosinophils and decreased levels of neutrophil surface markers,
as compared to wild type cells. This recapitulates the phenotype we observed in PLB-985
(Figure 5d–f). These experiments show that H1.2 and H1.4 cooperate to determine the neutrophil-
eosinophil cell fate decision in hematopoietic progenitor cells. Furthermore, our findings suggest
that, in vivo, the H1.2 and H1.4 deficiency is compensated by a different turnover of neutrophils and
by a dysregulated cytokine milieu to generate normal amounts of neutrophils during homeostasis.
Importantly, the bias towards eosinophils also exists in vivo, demonstrating that loss of H1.2 and
H1.4 affects the eosinophil lineage determination.
Loss of H1.2 and H1.4 affect neutrophil cell fate determination via
GATA-2
Two transcription factors required for eosinophil differentiation, GATA-1 and GATA-2, were upregu-
lated on mRNA level in H1.2 and H1.4 knockout lines (Figure 4d). GATA2 transcripts were higher
than GATA1 and transcript levels of both transcription factors at d0 inversely correlated with the
potential of PLB-985 to adopt a neutrophil-like cell fate (Figure 6—figure supplement 1a,b). Inter-
estingly, in mice GATA1 mRNA expression was higher than GATA2, and we could also see enhanced
expression of GATA1 in H1.2/H1.4-deficient bone marrow cells as compared to wild type cells (Fig-
ure 6—figure supplement 1c). Expression of GATA2 did not change in H1.2/H1.4-deficient murine
cells, but we saw a slight downregulation of CEBPA, which is in line with the expression profiles of
PLB-985 (Figure 6—figure supplement 1d,e).
We speculated that H1 subtypes affect neutrophil differentiation through either GATA-1 or
GATA-2. To test this hypothesis, we disrupted expression of GATA-1 and GATA-2 by CRISPR/Cas9
in PLB-985 and analyzed batch populations of various mutations at d4 of differentiation. We chose
Figure 4 continued
(PCA) of control and mutant PLB-985 during differentiation shows clustering according to experimental replicates and genotypes and separates
samples according to differentiation state. Lines indicate the center-of-mass trajectory for ‘normal’ (wild type and scr. cells), ‘hyper’ (H1 clones with
enhanced differentiation) and ‘hypo’ (H1 clones with reduced differentiation) samples. While lines deficient in H1.1, H1.3 and H1.5 already at d3 cluster
closely to wt and scr. at d7, indicating faster and more efficient differentiation, H1.2 and H1.4-deficient clones at d7 still only cluster with wt and scr. at
d3, indicating a stalled development.(d) Scatter dot plot depicting differentially expressed genes of H1.2 knockouts vs control cells at d0 of
differentiation (x axis) and H1.4 knockouts vs control cells at d0 of differentiation (y axis), color (alpha) indicates p-value of differential expression
between H1.2 and H1.4 at d0. Neutrophil genes such as neutrophil elastase (ELANE), proteinase 3 (PRTN3), cathepsin G (CTSG), azurocidin (AZU1) and
MPO are strongly downregulated in both conditions when compared to wt and scr., whereas eosinophil genes such as galectin 10 (CLC), interleukin-5
receptor alpha (IL5RA), GATA-1 (GATA1), GATA-2 (GATA2) or eosinophil peroxidase (EPX) are upregulated. (e) Gene set enrichment analysis of
indicated samples at d0 of differentiation shows enhanced expression of eosinophil and GATA-1 gene sets (see Materials and methods) in H1.2 and
H1.4-deficient lines, but not in other knockout conditions.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. RNA-seq expression tables.
Figure supplement 1. Transcriptional differences between H1-deficient clones during differentiation.
Figure supplement 2. Dysregulation of several transcription factors upon loss of H1 subtypes.
Figure supplement 3. Expression of eosinophil markers in PLB-985 upon loss of H1.2 or H1.4.
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Figure 5. Deletion of H1.2 or H1.4 biases murine hematopoietic cells towards an eosinophil lineage. (a–c) Analysis of circulating neutrophils and
eosinophils in wild type (wt) and H1.2/H1.4-double deficient mice (H1.2/H1.4 -/-). p Values, derived from unpaired two-tailed T tests, are indicated. (a)
Flow cytometry analysis of neutrophils (Gr1 positive, CD115 negative) in whole blood of adult age-matched animals (wt n = 15, H1.2/H1.4 - / - n = 14),
other immune cell types are shown in Figure 5—figure supplement 1. (b) Flow cytometry analysis of absolute amounts of neutrophils (Ly-6G positive
cells) in whole blood (n = 4). (c) Flow cytometry analysis of amounts of eosinophils (SiglecF positive) in whole blood (n = 4). H1.2/H1.4 - / - animals show
enhanced eosinophil numbers in circulation. d-f Lineage-negative hematopoietic stem cells were sorted from murine bone marrow and cultured for 6
days in the presence of various cytokines allowing differentiation into several immune cell lineages. Depicted are CD11b positive cells (d) and the
fraction of neutrophils (e) or eosinophils (f) within CD11b-positive cells. Each dot represents an independent experiment consisting of two mice per
genotype, the mean of the two wild type animals was set to one and the mean of the two H1.2/H1.4 - / - animals is depicted relative to wt. (a–f) Error
bars are SEM.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Gating strategies and circulating leukocytes.
Figure supplement 2. Leukocytes in circulation and bone marrow in homeostasis.
Figure supplement 3. Leukocytes in circulation and bone marrow upon casein injection.
Figure supplement 4. Eosinophil counts in bone marrow upon casein injection and in circulation.
Figure supplement 5. Differentially regulated ageing markers in H1.2/H1.4-deficient mice.
Figure supplement 6. Differentially regulated cytokines in H1.2/H1.4-deficient mice.
Figure supplement 7. Enhanced survival and granularity of H1.2/H1.4-deficient bone marrow cells and neutrophils.
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d4 because we assumed that cells still expressing GATA could outgrow GATA-deficient cells at later
time points. Interestingly, GATA-2 deficiency enhanced maturation of PLB-985, as indicated by an
increased ability to produce ROS in response to PMA (Figure 6—figure supplement 2a). In contrast,
GATA-1 knockout lines behaved as scr. cells (Figure 6—figure supplement 2a).
To test whether the differentiation phenotype of H1.2 and H1.4-deficient lines relied on GATA-2,
we performed a rescue experiment by generating double-deficient lines. We transduced scr. cells
and H1.2 or H1.4-deficient cells with GATA-1 and GATA-2 sgRNAs or with a scr. sgRNA as a control
and analyzed these populations at d4. Importantly, disruption of GATA-2 expression rescued ROS
production (Figure 6a–c) and CD11b expression (Figure 6d) in H1.2 and H1.4-deficient PLB-985.
Again, disruption of GATA-1 had no effect (Figure 6a–d). These experiments demonstrate that the
differentiation phenotype resulting from H1.2 and H1.4 deficiency depends on upregulation of
GATA-2 and, importantly, that loss of GATA-2 is sufficient to allow differentiation in the absence of
these H1 subtypes.
In a second approach, we treated PLB-985 with inhibitors for GATA-1 and GATA-2, starting treat-
ment one day before differentiation. Inhibition of GATA-2 enhanced CD11b expression of H1.2 or
H1.4-deficient lines (Figure 6e). To confirm the effect of GATA-2 inhibition on differentiation, we
measured mRNA expression of two genes, one that increased (aquaporin-9, AQP9) and one that
decreased (MPO) during differentiation (Figure 4—source data 1). As expected, H1.2 and H1.4-
deficient lines expressed less AQP9 and more MPO than scr. cells at d7 of differentiation (Figure 6—
figure supplement 2b,c). GATA-2 inhibition upregulated expression of AQP9 and downregulated
expression of MPO in H1.2 and H1.4 knockout lines at d7 of differentiation, indicating a rescue of
maturation (Figure 6—figure supplement 2b,c). In line with our results with CRISPR/Cas9-mediated
gene disruption, GATA-2 inhibition restored the capacity of H1.2 and H1.4-deficient clones to mount
an oxidative burst (Figure 6f–h). As expected, treatment with the GATA-1 inhibitor did not affect
maturation and function of PLB-985 of either genotype (Figure 6e,i–k). The combination of GATA-1
and GATA-2 inhibitors did not have an additive effect on PLB-985 maturation, confirming that
GATA-2 is the relevant transcription factor for the phenotype observed in H1.2 and H1.4-deficient
clones in the human cell system (Figure 6—figure supplement 2d). Importantly, the response to
either GATA-2 deficiency or inhibition was stronger in H1-deficient PLB-985 than in scr. cells. This is
in line with enhanced baseline expression of the transcription factor in H1.2 or H1.4-deficient clones.
These data show that H1.2 and H1.4 affect fate determination and subsequent neutrophil differentia-
tion and function at least partly through the regulation of GATA-2.
Discussion
We identified an unexpected role of H1 subtypes in neutrophil development; loss of H1.2 and H1.4
inhibits differentiation while deficiency in H1.1, H1.3 and H1.5 enhances it. We propose that in neu-
trophil precursors, H1 subtypes control the expression or activity of GATA-2, which determines cell
fate via transcription of neutrophil or eosinophil-specific genes. Enhanced expression of eosinophil
genes – or reduced expression of neutrophil-specific genes – disrupts normal maturation, leading to
prolonged proliferation and viability and reduced neutrophil function. Consistent with this, genetic
ablation or inhibition of GATA-2, but not GATA-1, rescued the differentiation of H1.2 and H1.4-defi-
cient cells. Interestingly, another study found that overexpression of GATA-2 in murine progenitor
cells switched their lineage determination from macrophages to a megakaryocyte state
(Kitajima et al., 2002). GATA-2 therefore acts as a key molecule for fate determination of immune
cells.
It is noteworthy that we found evidence of enhanced GATA1 mRNA expression in bone marrow
cells of H1.2/H1.4-deficient mice, but not of GATA2. The fold change of GATA1 in the absence of
H1.2 and H1.4 was much higher in PLB-985 than the fold change of GATA2. Furthermore, in mice
GATA1 mRNA was higher expressed than GATA2 mRNA. This could explain why we did not see an
upregulation of GATA2 in vivo. Another explanation could be that GATA2 upregulation does not
occur in lineage negative stem cells, but during the promyelocyte to neutrophil differentiation, while
the regulation of GATA1 is more robust. Enforced expression of both GATA-1 and GATA-2 can
induce eosinophil differentiation of human CD34+ hematopoietic stem cells (Hirasawa et al., 2002).
Interestingly, another study in murine cells showed that the eosinophil-promoting effect of GATA-2
depends strongly on the presence of C/EBP-a. Enforced expression of GATA-2 drove C/EBP-a
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Figure 6. Deficiency of H1.2 or H1.4 is rescued by inhibition of GATA-2. (a–c) Deficiency in GATA-2 but not GATA-1 rescues H1.2 and H1.4 deficiency.
Populations are batches of PLB-985. scr. (a), H1.4 (b) and H1.2 (c) knockout lines were transduced with an sgRNA against GATA1 or GATA2 or with a
scr. sgRNA as control and analyzed for ROS production in response to PMA at d4 of differentiation. (d) Deficiency in GATA-2 rescues CD11b expression
of H1.2 and H1.4-deficient PLB-985. CD11b expression of the indicated genotypes was measured at d4 of differentiation. (e) Treatment of PLB-985 with
Figure 6 continued on next page
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expressing precursor cells into the eosinophil lineage. However, in the absence of C/EBP-a, overex-
pression of GATA-2 induced mast cell and basophil development (Iwasaki et al., 2006). Therefore,
not only the expression levels of hematopoietic transcription factors, but also the order of their
expression is crucial for lineage determination. PLB-985 express C/EBP-a in the undifferentiated
state, and enhanced expression of GATA-2 can therefore explain the upregulation of eosinophil
markers we found in our experiments using this cell line.
Importantly, we observed a preference for eosinophil development in blood and in hematopoietic
stem cells isolated from the bone marrow of H1.2/H1.4-deficient mice. This demonstrates that the
bias towards the eosinophilic lineage also exists in vivo. However, adult H1.2/H1.4-deficient animals
had normal numbers of circulating neutrophils, indicating that neutrophil differentiation is compen-
sated. Interestingly the turnover rate or the longevity of neutrophils seemed to be affected in these
mice, since we found reduced amounts of young neutrophils in H1.2/H1.4-deficient animals. We also
found enhanced granularity and longevity of neutrophils isolated from H1.2/H1.4-deficient animals.
These two findings, reduced levels of CD62L (a marker of young neutrophils) and enhanced granular-
ity, are not consistent with the paradigm of young neutrophils being more granular (Adrover et al.,
2020). Our data therefore point to a dysregulation of neutrophil behavior and/or turnover. Interest-
ingly, however, the protein levels of H1.2 and H1.4 changed in human neutrophils during the time of
day, suggesting that linker histone levels might affect neutrophil ageing in vivo (Adrover et al.,
2020).
Neutropenia in peripheral tissues triggers de novo production of neutrophils in the bone marrow
(Stark et al., 2005), demonstrating that granulopoiesis in vivo is regulated by feedback loops. This
suggests that initial neutrophil deficiency in adult H1.2/H1.4-deficient mice is compensated by a dif-
ferent cytokine milieu. In line with this, we found altered expression of various cytokines and chemo-
kines, thus suggesting a dysregulated turnover or production of neutrophils in H1.2/H1.4-deficient
mice. It is noteworthy that we did not detect differences in the major cytokine driving neutrophil dif-
ferentiation, G-CSF. Casein-induced peritonitis upregulated G-CSF in both wt and H1.2/H1.4-defi-
cient animals. The serum levels of G-CSF during homeostasis were very low and probably under the
detection limit of our ELISA, and, if there are minor differences in G-CSF levels, we were not able to
measure them. We did, however, detect differences in the neutrophil-recruiting chemokine CXCL1
and in the pro-inflammatory cytokine IL-17, which could both also affect neutrophil turnover and
behavior.
Interestingly, in human breast cancer cells, combined loss of H1.2 and H1.4 leads to an upregula-
tion of an interferon signature (Izquierdo-Bouldstridge et al., 2017). Although we did not observe
an obvious interferon signature in H1.2 or H1.4-deficient PLB-985, it is possible that in H1.2/H1.4-
deficient mice some cell types contribute to immune cell differentiation via interferon-stimulated
genes.
H1 can act in redundant and subtype-specific ways (Hergeth and Schneider, 2015). Mice lacking
one or two H1 subtypes are viable and fertile (Fan et al., 2003). Analogously, PLB-985 deficient in
any of the five H1 subtypes that we disrupted were viable and did not show growth defects. This is
in contrast to another study, where shRNA-mediated knock down of H1.2 and H1.4 reduced cell
growth and viability in various non-immune cell lines (Sancho et al., 2008). We found that loss of
H1.2 and H1.4, in the context of neutrophil differentiation, enhanced viability, demonstrating cell
type specific effects of H1 subtypes.
H1 has long been considered a general repressor of transcription (Schlissel and Brown, 1984).
Accordingly, a study in human cells found that genomic regions associated with active transcription
Figure 6 continued
GATA-2 but not GATA-1 inhibitor rescues expression of CD11b, especially in lines deficient in H1.2 and H1.4. (f–k) ROS production of PLB-985 in
response to PMA is affected upon GATA-2, but not GATA-1 inhibition during differentiation. (f–k) PLB-985 ROS production was measured at d7 of
differentiation, indicated genotypes were treated with indicated inhibitors or solvent before the onset of differentiation and at d4. (a–k) Shown is the
mean -/+ SEM of 3 independent experiments.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. Expression of GATA-1, GATA-2 and C/EBP transcription factors in PLB-985 and murine bone marrow.
Figure supplement 2. H1.2 or H1.4 deficiency can be reverted by inhibition of GATA-2.
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were devoid of H1 subtypes (Izzo et al., 2013). However, murine embryonic stem cells that are tri-
ple-deficient in H1.2, H1.3 and H1.4 show a surprisingly low number of only 38 differentially
expressed genes when compared to wild type cells (Fan et al., 2005). Our data show that loss of H1
subtypes in more differentiated cells affects the expression of many genes with clear functional con-
sequences. We postulate that only a fraction of differentially expressed genes in PLB-985 is directly
regulated by H1 subtypes. The enhanced expression of lineage-determining transcription factors,
such as GATA-2, leads to further changes in the transcriptome and affects cell differentiation.
An important open question is: how do H1 subtypes control expression of GATA-2? It is possible
that H1 subtypes directly occupy the promoter or enhancer elements of GATA2 and silence its
expression. H1 subtype-specific binding to genomic regions has, for example, been shown for
human H1.5 (Li et al., 2012). Interestingly, H1.5 targeted over 20-fold more regions in differentiated
human lung fibroblasts than in embryonic stem cells and H1.5 binding led to chromatin compaction
and gene silencing. It is therefore tempting to speculate that similar mechanisms are at play during
neutrophil development. In addition to a direct repressive effect of H1.5, its binding to chromatin
was also associated with an enrichment of demethylation of histone H3 at lysine 9 (H3K9me2)
(Li et al., 2012). H3K9me2 is a posttranslational modification of a core histone that is associated
with a repressive chromatin state. H1 subtypes are therefore likely to regulate transcription via epi-
genetic marks on core histones. Furthermore, H1 subtypes themselves are posttranslationally modi-
fied in a subtype-specific manner (Hergeth and Schneider, 2015). Although less is known about H1
modifications than about core histones, it is likely that such modifications can determine subtype-
specific protein-protein interactions, chromatin binding properties or other features that subse-
quently cause transcriptional changes.
It is puzzling that vertebrates express so many different H1 subtypes. Although they are able to
compensate each other in ‘extreme’ situations, such as the loss of one or even two subtypes in a
whole organism (Fan et al., 2003), they may also have more subtle and specific functions. This study
contributes to our understanding of how different H1 subtypes initiate distinct transcriptional pro-
grams. Importantly, these programs appear to be evolutionarily conserved, since we found similar
responses in human and murine cells.
Our observations in the human cell line PLB-985 and murine stem cells ex vivo correlate with an
increase in the number of circulating eosinophils in H1.2/H1.4-deficient mice in vivo. We also
detected a disturbed cytokine milieu and a dysregulation of neutrophil ageing markers, granularity
and longevity in H1.2/H1.4-deficient animals, suggesting altered neutrophil turnover. This would be
in line with altered expression levels of H1.4 and H1.2 during human neutrophil ageing in circulation
(Adrover et al., 2020).
Notably, the number of neutrophils in the bone marrow and in circulation in H1.2/H1.4-deficient
mice was normal. Moreover, eosinophil numbers in bone marrow were the same between geno-
types. Taking all these observations and limitations together, we propose that H1 subtype regulation
in vivo is subject to compensatory mechanisms that eventually adjust the levels of neutrophils.
Indeed, it is expected that deletion of 2 out of 5 H1 subtypes, that probably affect the epigenetic
regulation of development, are subject to systemic adjustments. Further in vivo work, ideally also
aimed at investigating possible species differences between human and mouse, will likely elucidate
the relevance of H1 deficiency on granulopoiesis and neutrophil turnover in vivo during homeostasis
and inflammation.
In summary, we identified novel and opposing functions for specific H1 subtypes in granulopoie-
sis. H1 subtypes affect the lineage determination between neutrophils and eosinophils. We specu-
late that inappropriate expression of H1 subtypes in the hematopoietic compartment shapes
pathologies with neutrophil or eosinophil involvement, such as asthma. Our findings suggest that
linker histones represent another layer of complexity to the fascinating process of immune cell
differentiation.
Materials and methods
Cell lines
PLB-985 were kindly provided by Prof. Mary Dinauer, Washington University School of Medicine
(Zhen et al., 1993). THP-1 were from DSMZ-German Collection of Microorganisms and cell cultures.
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The cell lines were authenticated by STR authentication (eurofins Genomics); PLB-985 and THP-1
wildtype strains were mycoplasma negative (eurofins Genomics). The generated knockout lines were
not routinely tested for mycoplasma.
Antibodies and staining reagents
H1.2 antibody (PA5-32009, Invitrogen), H1.4 antibody (41328S, Cell Signaling), GAPDH antibody
(Cell Signaling, 2118), MPO antibody (A0398, Dako), Histone H3 antibody (ab1791, Abcam), galec-
tin-10 antibody (Abcam, 231964), SYTOX Green nucleic acid stain (Thermo Fisher Scientific) and 40,6-
diamidino-2-phenylindole (DAPI; Sigma) were used. All flow cytometry antibodies were from BD Bio-
sciences: human CD11b (557321), human Siglec-8 (347105), mouse CD11b (562605), mouse Ly-6G
(551461), mouse SiglecF (565527), mouse CD45 (561487), mouse CD3 (561798), mouse CD4
(552775), mouse CD8a (561093), mouse CD115 (565249), mouse GR1 (561103).
Chemicals and cytokines
Luminol (11050, AAT-Bioquest), horseradish peroxidase (31941, Serva), PMA (P8139, Sigma),
A23187 (Santa Cruz Biotechnology Inc), GATA-1 inhibitor (anagrelide, SML0846, Sigma), GATA-2
inhibitor (K-7174, HY-12743A, MedChemExpress) were used. Recombinant murine cytokines (IL-3,
IL-5, IL-9, GM-CSF, SCF, G-CSF) were from Peprotech.
Plasmids
All CRISPR/Cas9 gene disruptions were done using lentiCRISPRv2 (Shalem et al., 2014;
Sanjana et al., 2014). LentiCRISPRv2 was a gift from Feng Zhang (Addgene plasmid #52961; http://
n2t.net/addgene:52961; RRID:Addgene_52961). Lentiviral particles were produced using psPAX and
pMD2.G packaging plasmids in HEK293T cells.
sgRNA sequences and primers
All sgRNA sequences and primer sequences are listed in Supplementary file 1.
Donor consent
Human primary neutrophils, eosinophils, PBMCs and monocytes were isolated from blood samples
of healthy volunteers according to the declaration of Helsinki. All donors provided written informed
consent and all blood samples were collected from blood donated anonymously and with approval
from the ethics committee–Charité –Universitätsmedizin Berlin (EA1/0104/06).
Mice
Breeding of mice and isolation of blood and bone marrow were approved by the Berlin state author-
ity Landesamt für Gesundheit und Soziales (license numbers for breeding: ZH161, ZH122, license
numbers for isolation of cells: T0049/18, license number for injection of casein: H0085/18). All mice
were bred at the Max Planck Insitute for Infection Biology under specific pathogen-free conditions.
Animals were maintained on a 12 hr light/12 hr dark cycle and fed ad libitum. H1.2/H1.4-deficient
animals were provided by Prof. Arthur Skoultchi (Fan et al., 2003). Casein injection was performed
as described (Zhang et al., 1997). Briefly, mice were injected intraperitoneally with 1 ml of 7% casein
in the evening and again 12 hr later. 3 hr after the second injection, animals were sacrificed and
blood as well as bone marrow was isolated for analysis.
Primary cell isolation
Neutrophils were purified by centrifugation of whole blood over Histopaque-1119 (Sigma), followed
by centrifugation over a discontinuous Percoll gradient (Zhang et al., 1997). PBMCs were collected
from the upper phase after Histopaque-1119 centrifugation, washed and either used for RNA extrac-
tion or for isolation of monocytes by positive selection (CD14) with magnetic beads (130-050-201,
Miltenyi Biotec). Eosinophils were isolated from full blood using an isolation kit according to the
manufacturer’s instructions (130-092-010, Miltenyi Biotec).
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PLB-985 propagation and differentiation
PLB-985 were cultured in RPMI (RPMI 1640 medium, gibco) supplemented with 10% FCS, L-gluta-
mine and antibiotics (25030–024 and 15140–122, gibco), cells were passaged every 3–4 days. For
differentiation, cells were counted at d0 and 0.4  106 cells/ml were seeded in differentiation
medium (RPMI supplemented with 2.5% FCS, 0.5% dimethylformamide (DMF, D4551, Sigma), L-glu-
tamine and antibiotics), usually in six well plates in a total volume of 3 ml. At d4 of differentiation, 2
ml of differentiation medium were added per six well. At d7, cells were washed and passed over an
equal volume of Histopaque-1077 (Sigma) (centrifugation for 20 min at 800 x g, brakes off) to
remove debris and subsequently seeded at the required density for experiments in assay medium
(RPMI (without phenol red) containing 1% FCS, 0.5% DMF and L-glutamine).
Transmission electron microscopy
Cell suspensions, fixed in 2.5% glutaraldehyde, were sedimented and embedded in low melting aga-
rose (2% in PBS). Drops of agarose containing cells were then postfixed in 0,5% osmiumtetroxide,
contrasted with tannic acid and 2% uranyl acetate, dehydrated in a graded ethanol series and
embedded in epoxy resin. After polymerization, sections were cut at 60 nm and contrasted with
lead citrate. Specimens were analyzed in a Leo 906E transmission electron microscope at 100KV
(Zeiss, Oberkochen, DE) using a side mounted digital camera (Morada; SIS-Olympus Münster DE).
Analysis of ROS production from cells
Cells were seeded at 105/well of a white 96 well plate (Nunc) in triplicates in a final volume of 100 ml
in assay medium. HRP (1.2 U/ml) and luminol (50 mM) were added 10 min after seeding and 10 min
later cells were stimulated with 100 nM PMA. Luminescence signal was measured using a VICTOR
XLight Multimode Plate Reader (Perkin Elmer).
Analysis of cell death
Cells were seeded at 105/well of a 96 well plate in duplicates or triplicates in a final volume of 100
ml. The cell impermeable DNA dye SYTOX Green (50 nM) was added and 10 min later cells were
stimulated with 100 nM PMA or with 5 mM A23187. SYTOX Green fluorescence signal corresponding
to NET formation and cell death was measured over time using excitation/emission of 485/518 nm.
Alternatively, microscopy pictures were acquired using brightfield and GFP channels (for SYTOX
Green) in order to visualize the morphology of dead cells.
Analysis of phagocytosis
PLB-985 at d7 of differentiation were seeded at 5  105 in a final volume of 20 ml and stimulated
with a multiplicity of infection (MOI) 5 of fluorescently labelled (GFP-expressing or Alexa Fluor 488
conjugated) E. coli (Thermo Fisher Scientific). After incubation for 30 min at 37˚C on a shaker (300
rpm), the cells were washed twice with PBS and acquired by flow cytometry for the uptake of
bacteria.
Analysis of surface marker expression
PLB-985 and murine ex vivo differentiated bone marrow cells were stained at various time points of
differentiation with indicated surface marker antibodies for 20 min at 4˚C in PBS with 2% FCS,
washed and analyzed by flow cytometry using a MACS Quant Analyzer (Miltenyi Biotec). DAPI was
added just before acquisition to exclude dead cells.
Murine blood was stained the same way as described above, but after staining, samples were
incubated with eBioscience 1 Step Fix/Lyse Solution (invitrogen, 00-5333-54) for 1 hr to lyse erythro-
cytes before acquisition.
CRISPR/Cas9 screen
PLB-985 were transduced with a lentiviral library containing CRISPR/Cas9 sgRNAs (Shalem et al.,
2014) at an estimated MOI of <1. Cells were selected with puromycin (Sigma, 2.5 mg/ml), differentia-
tion was performed as described for wt PLB-985. At d7 of differentiation, cells were stimulated with
100 nM PMA for 16 hr and surviving cells were sorted by FACS. DNA extraction was performed by
DNeasy Blood and Tissue Kit (Qiagen) and PCR amplification was performed as described
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(Shalem et al., 2014). Reads were mapped to the library and abundance of sgRNAs was calculated
per condition. Genes with greater than 50% of their sgRNAs identified at values of at least 2-fold
overrepresentation in the PMA-treated group versus the control group were defined as hits.
Generation of CRISPR/Cas9 knockout lines
PLB-985 were transduced with lentiviral particles containing the sgRNA of interest cloned into lenti-
CRISPRv2, cells were selected with puromycin (2.5 mg/ml) and, if single clones were analyzed,
seeded at a density of 0.8 cells/well in 96 wells for limited dilution cloning. Clones were sequenced
using the OutKnocker protocol and software (Schmid-Burgk et al., 2014; Supplementary file 1).
Clones with out of frame indels leading to efficient gene disruption were used for subsequent
experiments.
For GATA-1 and GATA-2 disruption in scr., H1.2 and H1.4-deficient cells, sgRNAs targeting
GATA were cloned into a modified lentiCRISPRv2, in which the Cas9 sequence was exchanged for a
blasticidin resistance cassette. After transduction, cells were selected with blasticidin (50 mg/ml) and
used in batch populations for experiments.
RNA extraction and qRT-PCR
Cell samples were pelleted, resuspended and lysed in TRIzol Reagent (life technologies). RNA was
isolated by chloroform extraction and isopropanol precipitation. Similar amounts of total RNA were
used for RT-PCR (High Capacity cDNA Reverse Transcription Kit, 4368814, Thermo Fisher Scientific).
qRT-PCR was performed using SYBR Green (4385612, Thermo Fisher Scientific) on a QuantStudio 3
(Thermo Fisher Scientific).
RNA-sequencing
Total RNA of PLB-985 at various time points was isolated using RNeasy kit (Qiagen). Library prepara-
tion and illumina sequencing were performed by the Max Planck-Genome-centre Cologne, Germany
(https://mpgc.mpipz.mpg.de). The data were mapped to hg38.87 using STAR 2.5.2b (Dobin et al.,
2013) and differential expression analysis was performed using edgeR (McCarthy et al., 2012).
Gene level read counts from primary human cells at various steps of neutrophil differentiation were
retrieved from Blueprint (Adams et al., 2012) (http://www.blueprint-epigenome.eu, Datasets
EGAD00001002446, EGAX00001244028, EGAX00001244022 and EGAD00001002366) and analyzed
the same way. Gene module enrichment was performed using tmod package (Weiner and Domas-
zewska, 2016) and concordance and discordance was analyzed by calculating discordance scores
(Domaszewska et al., 2017). Eosinophil gene sets were retrieved from Harmonizome
(Rouillard et al., 2016) and Broad Institute (http://software.broadinstitute.org/gsea, Nakajima
set; Nakajima et al., 2001), GATA-1 gene set was generated by associating GATA-1 ChIP seq peaks
(GEO accession GSM1003608) to genes using ChIPseeker (Yu et al., 2015).
Ex vivo differentiation of murine bone marrow cells into neutrophils
and eosinophils
Murine bone marrow was extracted from the femurs and tibiae of adult age-matched mice. Cells
were flushed, erythrocytes were lysed by osmotic lysis, cells were washed and lineage-negative pre-
cursor cells were sorted by negative selection using magnetic beads (130-110-470, Miltenyi Biotec).
Lineage-negative cells were subsequently propagated analogous to the protocol described
(Dahlin et al., 2018). Briefly, cells were seeded in IMDM supplemented with 20% FCS, antibiotics,
L-glutamine and 0.1 mM 2-mercaptoethanol (Sigma), as well as with the recombinant cytokines IL-3
(20 ng/ml), IL-5 (50 ng/ml), IL-9 (50 ng/ml), GM-CSF (10 ng/ml) and SCF (20 ng/ml) for 6 days.
Statistical analysis
The descriptive statistics of all figure panels are mentioned in the respective figure legends. Popula-
tions of circulating leukocytes in murine blood were compared by a two-tailed, unpaired t test and p
values are indicated above the populations. RNA-seq data were analyzed as described in the respec-
tive methods section.
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Ballesteros I, Martin-Salamanca S, Aroca-Crevillen A, Chong SZ, Evrard M, Balabanian K, et al. 2019. A
neutrophil timer coordinates immune defense and vascular protection. Immunity 50:390–402. DOI: https://doi.
org/10.1016/j.immuni.2019.01.002, PMID: 30709741
Adrover JM, Aroca-Crevillén A, Crainiciuc G, Ostos F, Rojas-Vega Y, Rubio-Ponce A, Cilloniz C, Bonzón-
Kulichenko E, Calvo E, Rico D, Moro MA, Weber C, Lizasoaı́n I, Torres A, Ruiz-Cabello J, Vázquez J, Hidalgo A.
2020. Programmed ’disarming’ of the neutrophil proteome reduces the magnitude of inflammation. Nature
Immunology 21:135–144. DOI: https://doi.org/10.1038/s41590-019-0571-2, PMID: 31932813
Bednar J, Garcia-Saez I, Boopathi R, Cutter AR, Papai G, Reymer A, Syed SH, Lone IN, Tonchev O, Crucifix C,
Menoni H, Papin C, Skoufias DA, Kurumizaka H, Lavery R, Hamiche A, Hayes JJ, Schultz P, Angelov D, Petosa
C, et al. 2017. Structure and dynamics of a 197 bp Nucleosome in Complex with Linker Histone H1. Molecular
Cell 66:384–397. DOI: https://doi.org/10.1016/j.molcel.2017.04.012, PMID: 28475873
Borregaard N. 2010. Neutrophils, from marrow to microbes. Immunity 33:657–670. DOI: https://doi.org/10.
1016/j.immuni.2010.11.011, PMID: 21094463
Dahlin JS, Hamey FK, Pijuan-Sala B, Shepherd M, Lau WWY, Nestorowa S, Weinreb C, Wolock S, Hannah R,
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